Innovation in Artificial Intelligence: Leading companies in the detection of DNA polymorphisms for the pharmaceutical industry
The pharmaceutical The industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, the severity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapy and artificial intelligence (AI). In the past three years alone, more than 633,000 patents have been …